Atopic Dermatitis

ITCH: Mechanisms and Treatment

Volumn , Issue , 2014, Pages 19-31

  Darsow, Ulf ^a   Raap, Ulrike ^b   Ständer, Sonja ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85101052549     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16573-7     Document Type: Chapter

References (72)

1. Bilsborough, J., Leung, D. Y., Maurer, M., Howell, M., Boguniewicz, M., Yao, L., Storey, H. et al. (2006). IL-31 is associated with cutaneous lymphocyte antigen-positive skin hom-ing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 117(2): 418-425.
2. Bromm, B., Scharein, E., Darsow, U., and Ring, J. (1995). Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci. Lett. 187: 157-160.
3. Carstens, E. E., Carstens, M. I., Simons, C. T., and Jinks, S. L. (2010). Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats. Neuroreport. 21(4): 303-308.
4. Chrostowska-Plak, D., Reich, A., and Szepietowski, J. C. (2012). Relationship between itch and psychological status of patients with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 27: 339-342.
5. Chrostowska-Plak, D., Salomon, J., Reich, A., and Szepietowski, J. C. (2009). Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm. Venereol. 89: 379-383.
6. Cookson, W. O., and Moffatt, M. F. (2002). The genetics of atopic dermatitis. Curr. Opin. Allergy Immunol. 2: 383-387.
7. Costello, R. W., Schofield, B. H., Kephart, G. M., Gleich, G. J., Jacoby, D. B., and Fryer, A. D. (1997). Localization of eosinophils to airway nerves and effects on neuronal M2 musca-rinic receptor function. Am. J. Physiol. 273(1 Pt 1): L93-L103.
8. Darsow, U., Mautner, V. F., Bromm, B., Scharein, E., and Ring, J. (1997). The Eppendorf Pruritus Questionnaire. Hautarzt 48: 730-733.
9. Darsow, U., Ring, J., Scharein, E., and Bromm, B. (1996). Correlations between histamine-induced wheal, flare and itch. Arch. Dermatol. Res. 288: 436-441.
10. Darsow, U., Scharein, E., Simon, D., Walter, G., Bromm, B., and Ring, J. (2001). New aspects of itch pathophysiology: Component analysis of atopic itch using the “Eppendorf Itch Questionnaire.” Int. Arch. Allergy Immunol. 124: 326-331.
11. Darsow, U., Wollenberg, A., Simon, D., Taïeb, A., Werfel, T., Oranje, A., Gelmetti, C. et al. for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force. (2010). ETFAD/EADV Eczema Task Force 2009 position paper on diagnosis and treatment of atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 24: 317-328.
12. Dawn, A., Papoiu, A. D., Chan, Y. H., Rapp, S. R., Rassette, N., and Yosipovitch, G. (2009). Itch characteristics in atopic dermatitis: Results of a web-based questionnaire. Br. J. Dermatol. 160: 642-644.
13. Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S. et al. (2004). Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5(7): 752-760.
14. Ezzat, M. H. M., Hasan, Z. E., and Shaheen, K. Y. A. (2011). Serum measurement of inter-leukin-31 (IL-31) in paediatric atopic dermatitis: Elevated levels correlate with severity scoring. J. Eur. Acad. Dermatol. Venereol. 25(3): 334-349.
15. Foster, E. L., Simpson, E. L., Fredrikson, L. J., Lee, J. J., Lee, N. A., Fryer, A. D., and Jacoby, D. B. (2011). Eosinophils increase neuron branching in human and murine skin and in vitro. Plos One. 6(7): e22029.
16. Grimstad, O., Sawanobori, Y., Vestergaard, C., Bilsborough, J., Olsen, U. B., Grønhøj-Larsen, C., and Matsushima, K. (2009). Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: A model of atopic dermatitis. Exp. Dermatol. 18(1): 35-43.
17. Haas, S., Capellino, S., Phan, N. Q., Bohm, M., Luger, T. A., Straub, R. H., and Ständer, S. (2010). Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J. Dermatol. Sci. 58(3): 193-197.
18. Hafenreffer, S. (1660). Nosodochium, in quo cutis, eique adaerentium partium, affectus omnes, singulari methodo, et cognoscendi et curandi fidelissime traduntur. Kühnen, B. (Ed.). Ulm: Kűln, pp. 98-102.
19. Hägermark, O., and Wahlgren, C. F. (1992). Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms. J. Dermatol. Sci. 4: 55-62.
20. Hanifin, J. M., Ling, M. R., Langley, R., Breneman, D., and Rafal, E. (2001). Tacrolimus oint-ment for the treatment of atopic dermatitis in adult patients. Part I, Efficacy. J. Am. Acad. Dermatol. 44: S28-S38.
21. Hanifin, J. M., and Rajka, G. (1980). Diagnostic features of atopic dermatitis. Acta Derm. Venereol. Suppl. 92: 44-47.
22. Hannuksela, M., Kalimo, K., Lammintausta, K., Turjanmaa, K., Vajionen, E., and Coulie, P. J. (1993). Dose ranging study: Cetirizine in the treatment of atopic dermatitis in adults. Ann. Allergy 70: 127-133.
23. Heise, R., Neis, M. M., Marquardt, Y., Joussen, S., Heinrich, P. C., Merk, H. F., Hermanns, H. M., and Baron, J. M. (2009). IL-31 receptor alpha expression in epidermal keratino-cytes is modulated by cell differentiation and interferon gamma. J. Invest. Dermatol. 129(1): 240-243.
24. Hon, K. L., Lam, M. C., Wong, K. Y., Leung, T. F., and Ng, P. C. (2007). Pathophysiology of nocturnal scratching in childhood atopic dermatitis: The role of brain-derived neuro-trophic factor and substance P. Br. J. Dermatol. 157(5): 922-925.
25. Inagaki, N., Shiraishi, N., Igeta, K., Nagao, M., Kim, J. F., Chikumoto, T., Itoh, T., Katoh, H., Tanaka, H., and Nagai, H. (2010). Depletion of substance P, A mechanism for inhibition of mouse scratching behavior by tacrolimus. Eur. J. Pharmacol. 626: 283-289.
26. Jekler, J., and Larkö, O. (1990). Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: A paired-comparison study. J. Am. Acad. Dermatol. 22: 49-53.
27. Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C. et al. (2004). Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 113: 832-836.
28. Kiehl, P., Falkenberg, K., Vogelbruch, M., and Kapp, A. (2001). Tissue eosinophilia in acute and chronic atopic dermatitis: A morphometric approach using quantitative image analysis of immunostaining. Br. J. Dermatol. 145(5): 720-729.
29. Klein, P. A., and Clark, R. A. F. (1999). An evidence-based review of the efficacy of antihista-mines in reliefing pruritus in atopic dermatitis. Arch Dermatol. 135: 1522-1525.
30. Kobayashi, H., Gleich, G. J., Butterfield, J. H., and Kita, H. (2002). Human eosinophils pro-duce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood. 99(6): 2214-2220.
31. Liu, Q., Tang, Z. X., Surdenikova, L., Kim, S., Patel, K. N., Kim, A., Ru, F. et al. (2009). Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell. 139(7): 1353-1365.
32. Luger, T., van Leent, E. J. M., Graeber, M., Hedgecock, S., Thurston, M., Kandra, A., Berth-Jones, J. et al. (2001). SDZ ASM 981: An emerging safe and effective treatment for atopic dermatitis. Br. J. Dermatol. 144: 788-794.
33. Melzack, R. (1975). The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1: 277-299.
34. Mihm, M. C., Soter, N. A., Dvorak, H. F., and Austen, K. F. (1976). The structure of normal skin and the morphology of atopic eczema. J. Invest. Dermatol. 67: 305-312.
35. Murray, R., and Rees, J. L. (2011). Are subjective accounts of itch to be relied on? The lack of relation between visual analogue itch scores and actigraphic measures of scratch. Acta Derm. Venereol. 91: 18-23.
36. Nakano, T., Andoh, T., Lee, J. B., and Kuraishi, Y. (2008). Different dorsal horn neurons res-ponding to histamine and allergic itch stimuli. Neuroreport. 19(7): 723-726.
37. Niyonsaba, F., Ushio, H., Hara, M., Yokoi, H., Tominaga, M., Takamori, K., Kajiwara, N. et al. (2010). Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J. Immunol. 184(7): 3526-3534.
38. O’Reilly, M., Alpert, R., Jenkinson, S., Gladue, R. P., Foo, S., Trim, S., Peter, B., Trevethick, M., and Fidock, M. (2002). Identification of a histamine H-4 receptor on human eosin-ophils-Role in eosinophil chemotaxis. J. Recept. Signal Transduct. Res 22(1-4): 431-448.
39. Pfab, F., Valet, M., Napadow, V., Tölle, T., Behrendt, H., Ring, J., and Darsow, U. (2012). Itch and the brain. In Allergy and the Nervous System. Bienenstock, J. (ed.). Chem. Immunol. Allergy 98: 254-266.
40. Pfab, F., Valet, M., Sprenger, T., Huss-Marp, J., Athanasiadis, G. I., Baurecht, H. J., Konstantinow, A. et al. (2010). Temperature modulated histamine-itch in lesional and non-lesional skin in atopic eczema-A combined psychophysical and neuroimaging study. Allergy 65: 84-94.
41. Raap, U., Deneka, N., Bruder, M., Kapp, A., and Wedi, B. (2008). Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects. Clin. Exp. Allergy. 38(9): 1493-1498.
42. Raap, U., Goltz, C., Deneka, N., Bruder, M., Renz, H., Kapp, A., and Wedi, B. (2005). Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J. Allergy Clin. Immunol. 115(6): 1268-1275.
43. Raap, U., and Kapp, A. (2010). Neurotrophins in healthy and diseased skin. G. Ital. Dermatol. Venereol. 145(2): 205-211.
44. Raap, U., Weissmantel, S., Gehring, M., Eisenberg, A. M., Kapp, A., and Folster-Holst, R. (2012). IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr. Allergy Immunol. 23(3): 285-288.
45. Raap, U., Werfel, T., Goltz, C., Deneka, N., Langer, K., Bruder, M., Kapp, A., Schmid-Ott, G., and Wedi, B. (2006). Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy. 61(12): 1416-1418.
46. Raap, U., Wichmann, K., Bruder, M., Stander, S., Wedi, B., Kapp, A., and Werfel, T. (2008). Correlation of IL-31 serum levels with severity of atopic dermatitis. J. Allergy Clin. Immunol. 122(2): 421-423.
47. Ring, J. (2004). Allergy in Practice. Heidelberg: Springer.
48. Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink-Wagner, A., Gelmetti, C., Gieler, G. et al. (2012). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J. Eur. Acad. Dermatol. Venereol. 26: 1045-1060.
49. Ring, J., Przybilla, B., and Ruzicka, T. (eds.) (2006). Handbook of Atopic Eczema, 2nd ed. Heidelberg: Springer.
50. Schultz-Larsen, F. (1985). Atopic Dermatitis. Etiological Studies Based on a Twin Population. Kopenhagen: Laegeforeningens.
51. Siepmann, D., Luger, T. A., and Ständer, S. (2008). Antipruritic effect of cyclosporine micro-emulsion in prurigo nodularis: Results of a case series. J. Dtsch. Detmatol. Ges. 6: 941-946.
52. Solomon, A., Aloe, L., Pe’er, J., Frucht-Pery, J., Bonini, S., Bonini, S., and Levi-Schaffer, F. (1998). Nerve growth factor is preformed in and activates human peripheral blood eosin-ophils. J. Allergy Clin. Immunol. 102(3): 454-460.
53. Sonkoly, E., Muller, A., Lauerma, A. I., Pivarcsi, A., Soto, H., Kemeny, L., Alenius, H. et al. (2006). IL-31: A new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol. 117(2): 411-417.
54. Ständer, S., and Luger, T. (2010). Itch in atopic dermatitis-Pathophysiology and treatment. Acta Dermatovenerol. Croat. 18: 289-296.
55. Ständer, S., Siepmann, D., Herrgott, I., Sunderkotter, C., and Luger, T. A. (2010). Targeting the neurokinin receptor 1 with aprepitant: A novel antipruritic strategy. Plos One. 5(6): e10968.
56. Ständer, S., and Weisshaar, E. (2012). Medical treatment of pruritus. Expert Opin. Emerg. Drugs 17: 335-345.
57. Sugiura, H., Omoto, M., Hirota, Y., Danno, K., and Uehara, M. (1997). Density and fine struc-ture of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol. Res. 289(3): 125-131.
58. Sun, Y. G., and Chen, Z. F. (2007). A gastrin-releasing peptide receptor mediates the itch sen-sation in the spinal cord. Nature. 448(7154): 700-703.
59. Szegedi, K., Kremer, A. E., Kezic, S., Teunissen, M. B., Bos, J. D., Luiten, R. M., Res, P. C., and Middelkamp-Hup, M. A. (2012). Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp. Dermatol. 21(6): 431-416.
60. Takano, N., Sakurai, T., and Kurachi, M. (2005). Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J. Pharmacol. Sci. 99(3): 277-286.
61. Takaoka, A., Arai, I., Sugimoto, M., Yamaguchi, A., Tanaka, M., and Nakaike, S. (2005). Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur. J. Pharmacol. 516(2): 180-181.
62. Tedeschi, A., Asero, R., Marzano, A. V., Lorini, M., Fanoni, D., Berti, E., and Cugno, M. (2009). Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy. 64(11): 1616-1622.
63. Tominaga, M., Ogawa, H., and Takamori, K. (2009). Histological characterization of cutane-ous nerve fibers containing gastrin-releasing peptide in NC/Nga mice: An atopic derma-titis model. J. Invest. Dermatol. 129: 2901-2905.
64. Tominaga, M., Tengara, S., Kamo, A., Ogawa, H., and Takamori, K. (2009). Psoralen-ultraviolet A therapy alters epidermal Sema 3A and NGF levels and modulates epider-mal innervation in atopic dermatitis. J. Dermatol. Sci. 55: 40-46.
65. Toyoda, M., Nakamura, M., Makino, T., Hino, T., Kagoura, M., and Morohashi, M. (2002). Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br. J. Dermatol. 147(1): 71-79.
66. Toyoda, M., Nakamura, M., Makino, T., and Morohashi, M. (2003). Localization and content of nerve growth factor in peripheral blood eosinophils of atopic dermatitis patients. Clin. Exp. Allergy. 33(7): 950-955.
67. Urashima, R., and Mihara M. (1998). Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch. 432(4): 363-370.
68. Wahlgren, C. F., Hagermark, O., and Bergstrom, R. (1991). Patients’ perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis. Acta Derm. Venereol. 71(6): 488-494.
69. Wahlgren, C. F., Scheynius, A., and Hägermark, Ö. (1990). Antipruritic effect of oral cyclo-sporin A in atopic dermatitis. Acta Derm. Venereol. 70: 323-329.
70. Weidinger, S., O’Sullivan, M., Illig, T., Baurecht, H., Depner, M., Rodriguez, E., Ruether, A. et al. (2008). Mutations, atopic eczema, hay fever, and asthma in children. J. Allergy Clin. Immunol. 121: 1203-1209.
71. Weissenbacher, S., Bacon, T., Targett, D., Behrendt, H., Ring, J., and Darsow, U. (2005). Atopy patch test-Reproducibility and elicitation of itch in different application sites. Acta Derm. Venereol. 85: 147-151.
72. Williams, H. C., Burney, P. J. G., Pembroke, A. C., and Hay, R. J. (1996). Validation of the UK diagnostic criteria for atopic dermatitis in a population setting. Br. J. Dermatol. 135: 12-17.